La Mirada, CA (PRWEB) June 17, 2014
With the Clinical Laboratory Improvement Amendment (CLIA) License, Healthpointe’s Dr. Sam Truong is now able to perform high complexity testing and treatment for skin cancer (along with other diseases) using the Mohs Surgery Technique. As an American Board of Dermatology certified physician, Dr. Sam Truong has been at the forefront of adopting new technologies and procedures for his patients. Dr. Truong is the current chief dermatologist at Healthpointe Medical Group who specializes in medical, surgical and cosmetic dermatology along with conditions affecting the skin, hair and nails. Indeed, Dr. Truong garners extensive training in skin cancer detection and surgery, as well as experience in managing various other conditions such as acne, dermatitis, eczema, hair loss, psoriasis, rosacea, and vitiligo. Dr. Sam Truong utilizes countless surgical procedures to assist in treating skin cancer; one in particular is the Mohs Technique. Although new treatments for skin cancer are appearing and evolving rapidly throughout the years, the Mohs Micrographic Surgical Technique has been deemed the most precise and effective solution to treat skin cancer. Dr. Truong will be utilizing the Mohs Technique to not only treat skin cancer, but also other skin conditions such as fungus. The Mohs Micrographic Surgery has been embraced by an increasing number of surgeons, which has resulted in a huge increase of its use for the treatment of skin cancer. It is highly beneficial and thanks to the new CLIA license, Dr. Sam Truong will now be able to utilize more complex testing for skin cancer with the utilization of the Mohs Surgery Technique. For more information on skin cancer and any other skin conditions, visit Dr. Sam Truong at Healthpointe. Healthpointe’s services are offered during regular business hours: Monday-Friday 9-6. For more information, contact Healthpointe at 844-887-7882 or visit the Healthpointe Website.
About Clinical Laboratory Improvement Amendment: The Clinical Laboratory Improvement Amendment (CLIA), established in 1988, consists of United States federal regulatory standards that apply to all clinical laboratory testing (with the exception of clinical trials and basic research) that are performed on individuals in the United States. The objective of CLIA is to overall ensure quality laboratory testing for health assessment and regulates laboratory testing. In other words, CLIA approves laboratories that help healthcare providers monitor, diagnose, prevent, and treat specific diseases and illnesses that are affecting their patients.
About Healthpointe: Healthpointe is a leading multidisciplinary healthcare organization offering a full range of medical services in practice locations throughout Southern California (Los Angeles, Orange, San Bernardino and Riverside counties). As a highly regarded musculoskeletal group, we have a personal investment in the highest level of service, and we are proud of our record of excellence over the last four decades with private patients, injured workers, urgent care, personal injuries, and professional and non-professional athletes. Leading our organization is a dynamic team of healthcare professionals who continually strive to be at the forefront of medical innovation and healthcare service delivery. For more information, a complete list of services, and Healthpointe locations, visit http://www.Healthpointemd.net